Cover Image
市場調查報告書

遠程醫療設備市場預測

Telemedicine Devices Market Forecast 2014-2024

出版商 Visiongain Ltd 商品編碼 297005
出版日期 內容資訊 英文 168 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
遠程醫療設備市場預測 Telemedicine Devices Market Forecast 2014-2024
出版日期: 2014年03月05日 內容資訊: 英文 168 Pages
簡介

全球整體遠程醫療設備市場收益預測將在2014年達到10億4,800萬美元。

本報告提供全球遠程醫療設備市場相關調查,提供收益預測,資料與趨勢·機會·展望的分析,次級市場的收益預測,主要12個國家的收益預測,再加上主要10間企業簡介,市場影響因素分析,及專家的見解等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 遠程醫療·遠端保健的簡介

  • 遠程醫療,遠端保健及遠距照護:簡潔的定義
  • 得病率的增加:全球概要
  • 遠程醫療:歷史
  • 行動醫療:行動通訊轉換醫療保健
  • 遠程醫療一般所採用的檢測設備
  • 醫療設備分類系統
  • 醫療設備的法規

第3章 全球遠程醫療市場:治療指標別

  • 全球醫療設備市場
  • 遠程醫療:全球市場概要
  • 心臟疾病市場的遠程醫療設備
  • 慢性阻塞性肺病·氣喘市場的遠程醫療設備
  • 糖尿病市場的遠程醫療設備
  • 心理健康相關疾病市場的遠程醫療設備
  • 其他疾病的治療所採用的遠程醫療設備

第4章 主要國家市場

  • 遠程醫療設備市場:各地區收益
  • 主要國家市場:預測
  • 各地區的遠程醫療設備市場:分析與預測

第5章 遠程醫療·平板電腦·行動醫療:分析與趨勢

  • 內容設備綁定的遠程醫療
  • 促進遠程醫療開發的要素
  • 行動醫療
  • 開發平台企劃

第6章 遠程醫療市場主要企業

  • 3M:全世界的健康資訊系統供應商
  • Aerotel Medical Systems
  • AGFA Healthcare
  • AMD Global Telemedicine Inc
  • CardioComm
  • Honeywell HomMed
  • Medtronic
  • Philips Healthcare
  • Siemens Healthcare
  • Telcare

第7章 定性分析

  • 遠程醫療設備市場SWOT分析
  • 優勢
  • 弱點
  • 機會
  • 威脅

第8章 專家的見解

第9章 結論

  • 市場概要
  • 糖尿病照護用遠程醫療設備正在急速成長
  • 技術促進了已發展的經濟各國市場成長

圖表清單

目錄

Telemedicine Devices - assess products, developments, and revenue prospects

What does the future hold for telemedicine devices? Visiongain's brand new report shows you the potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 168 page report provides 150 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of four exclusive expert opinion interviews from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales:

  • Stacey Force, Vice President of Marketing, Honeywell HomMed
  • Jason Gorevic, Chief Executive Officer, Teladoc
  • David Rubin, Chief Executive Officer, Aerotel Medical Systems
  • Amnon Gavish, Senior Vice President of Vertical Solutions, Vidyo; and Marty Hollander, Vidyo Evangelist, Vidyo

You will find prospects for key submarkets

In addition to analyses of the overall world market, you will see revenue forecasting of four world-level submarkets to 2024:

  • Telemedicine devices for cardiac diseases
  • Telemedicine devices for asthma & COPD
  • Telemedicine devices for mental-health related illnesses
  • Telemedicine devices used in the treatment for other illnesses

Our investigation shows business research and analysis with individual revenue forecasts and discussions. How will those telemedicine devices markets expand? Which applications will generate the most revenues? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects in the leading regions and countries?

Events and progress worldwide will influence the market.

In our study you will find individual revenue forecasts to 2024 for 12 national markets:

  • US
  • Japan
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • China
  • South Korea
  • Russia
  • India
  • Brazil
  • Row

Many opportunities exist within the telemedicine devices market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.

Leading companies and potential for market growth

Overall world revenue for the telemedicine devices market will reach $1048m in 2014, our study forecasts. We predict strong revenue growth from 2014 to 2024. Our research shows you what organisations hold greatest potential. See profiles of 10 leading companies, including these:

  • 3M
  • Aerotel Medical Systems
  • AGFA Healthcare
  • AMD Global Telemedicine
  • CardioComm
  • Honeywell HomMed
  • Medtronic
  • Philips Healthcare
  • Siemens Healthcare
  • Telcare

In general, a company profile gives you the following information:

  • Overview of the company, including its history in the telemedicine devices market
  • Discussion of a company's activities and outlook including descriptions of leading products
  • Recent financial results
  • Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures

What issues will affect the telemedicine devices market?

Our new report discusses issues and events affecting the telemedicine devices market. You will find discussions, including qualitative analyses:

  • Rising popularity of home monitoring
  • Increasing investments from telecommunication companies
  • Increasing barriers to market entry
  • Infrastructure challenges in developing economies
  • Increasing patient desire to use their own devices to monitor health

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Telemedicine Devices Market Forecast 2014-2024: Telehealth, mHealth & Future Prospects for Leading Companies report helps you

In summary, our 168 page report gives you the following knowledge:

  • Revenues forecasts to 2024 for the overall world telemedicine devices market and 4 submarkets - discover the industry's prospects, finding promising places for investments and revenues
  • Assessment of 10 leading companies, and others, discovering activities and outlooks
  • Market forecasting to 2024 for 12 leading national markets - USA, Japan, Germany, France, UK, Spain, Italy, South Korea, Brazil, Russia, India, China and RoW
  • View opinions from our survey, seeing interviews with authorities
  • Investigation of competition and opportunities influencing sales
  • Discussion of what stimulates and restrains the telemedicine devices market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how our report could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the telemedicine devices market. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Executive Summary

  • 1.1. Market Highlights
  • 1.2. Overview of the Report Content
  • 1.3. Research and Analysis Methods
  • 1.4. Glossary of Terms Related to Telemedicine

2. An Introduction to Telemedicine and Telehealth

  • 2.1. Telemedicine, Telehealth, and Telecare: A Concise Definition
    • 2.1.1. Telecare: An All-Encompassing Field
    • 2.1.2. Telehealth: For Monitoring and Health Maintenance
    • 2.1.3. Telemedicine: Consultation, Diagnosis, Treatment
  • 2.2. Rising Disease Prevalence: A Global Picture
  • 2.3. Telemedicine: A Journey through History
  • 2.4. mHealth: Mobile Communications to Transform Healthcare
  • 2.5. Commonly Used Measuring Devices in Telemedicine
    • 2.5.1. Blood Glucose Monitors
    • 2.5.2. Blood-Pressure Monitors
    • 2.5.3. Weight Scales
    • 2.5.4. Pulse Oximeters
    • 2.5.5. Peak Flow Meters
  • 2.6. Medical Devices Classification Systems
    • 2.6.1. The US Medical Devices Classification System
    • 2.6.2. The EU Medical Devices Classification System
  • 2.7. Regulation of Medical Devices
    • 2.7.1. The US Approval and Regulation System
    • 2.7.2. The EU Approval and Regulation System
      • 2.7.2.1. Post-marketing Surveillance in the EU

3. The Global Telemedicine Market: by Therapeutic Indication 2014-2024

  • 3.1. The Global Medical Device Market in 2013
  • 3.2. Telemedicine: Global Market Overview
    • 3.2.1. The Global Telemedicine Devices Market in 2013
    • 3.2.2. Global Telemedicine Devices: Market Forecast 2014-2024
    • 3.2.3. Changing Market Shares by Sector 2014-2024
  • 3.3. Telemedicine Devices for Cardiac Diseases Market 2014-2024
    • 3.3.1. Cardiac Diseases: A Major Cause of Death in Developed Economies
    • 3.3.2. Telemedicine Devices for Cardiac Diseases: Market Forecast 2014-2024
  • 3.4. Telemedicine Devices for COPD and Asthma Market 2014-2024
    • 3.4.1. COPD and Asthma: Rising Prevalence
    • 3.4.2. Telemedicine Devices for COPD and Asthma: Market Forecast 2014-2024
  • 3.5. Telemedicine Devices for Diabetes Market 2014-2024
    • 3.5.1. Diabetes: Rapid Technological Advances in Monitoring and Treatment
    • 3.5.2. Telemedicine Devices for Diabetes: Market Forecast 2014-2024
  • 3.6. Telemedicine Devices for Mental-health Related Illnesses Market 2014-2024
    • 3.6.1. Telemedicine Devices for Use in Mental-health Related Illnesses
    • 3.6.2. The Issue of Capacity, Consent, and Privacy in the Treatment of Mental Disorders
    • 3.6.3. Cognitive Behaviour Therapy and the Use of Apps in the Management of Mental Disorders
    • 3.6.4. The Phyode W/ME and the Life Spectrum Analyzer
    • 3.6.5. Telemedicine Devices for Mental-health Related Illnesses: Market Forecast 2014-2024
  • 3.7. Telemedicine Devices Used in the Treatment of Other Illnesses
    • 3.7.1. Obstructive Sleep Apnea and Post Traumatic Stress Disorder
    • 3.7.2. Telemedicine Devices Used in the Treatment of Other Illnesses: Market Forecast 2014-2024

4. Leading National Markets 2014-2024

  • 4.1. The Telemedicine Devices Market by Regional Revenue
    • 4.1.1. The Global Distribution of Telemedicine in 2013
  • 4.2. Leading National Markets: Forecast, 2014-2024
    • 4.2.1. Changing Market Shares by Region, 2014-2024
  • 4.3. Regional Telemedicine Devices Markets: Analysis and Forecasts, 2014-2024
    • 4.3.1. United States: The Largest Telemedicine Market
    • 4.3.2. The EU5KKKKK Markets: Increasing Focus on Access to Quality Healthcare
      • 4.3.2.1. EU5: Changing Market Shares by Country, 2014-2024
      • 4.3.2.2. Germany: Biggest European Telemedicine Market
      • 4.3.2.3. The UK: Government Initiatives Driving Telemedicine Uptake
      • 4.3.2.4. France: A Tale of Reimbursement Struggles and Cost Cutting
      • 4.3.2.5. Spain: Austerity Drive Weighing On Medical Technology
      • 4.3.2.6. Italy: Ageing Population and Reforms in Healthcare Financing
    • 4.3.3. Japan: Language Barrier and Complex Regulatory Guidelines Hindering Growth
    • 4.3.4. China: A Great Leap Forward in Teleconferencing
    • 4.3.5. South Korea: Rebranding Efforts Will Contribute to Market Growth
    • 4.3.6. Russia: Pressing Need for Healthcare Extension to Remote Territories
    • 4.3.7. India: A Rapidly Growing Medical Technology Market
    • 4.3.8. Brazil: Social Inequalities and Uneven Healthcare Distribution

5. Telemedicine, Telehealth, and mHealth: Analysis and Trends

  • 5.1. Telemedicine as a Package of Connected Devices
    • 5.1.1. Telemedicine: Applications and Uses
    • 5.1.2. Telemedicine: Issues Surrounding its Implementation
  • 5.2. Factors Which Could Facilitate Telemedicine Development
    • 5.2.1. The Establishment of National Agencies
    • 5.2.2. Collaboration between Scientific Bodies
    • 5.2.3. Legislative Interventions: The Affordable Care Act
  • 5.3. mHealth
    • 5.3.1. Mobile Devices Have the Potential to Become Powerful Medical Tools
    • 5.3.2. The Rise of Mobile Medical Applications
    • 5.3.3. Functions of mHealth
    • 5.3.4. mHealth and GPS Tracking: A Possible Marriage with Benefits
    • 5.3.5. The mHealth Initiative: An ITU and WHO Partnership
    • 5.3.6. Overcoming the Obstacles to mHealth Uptake
    • 5.3.7. Recommended Actions for Increasing mHealth Uptake
      • 5.3.7.1. Maintain Low Costs
      • 5.3.7.2. Gain the Approval of the Healthcare Practitioners
      • 5.3.7.3. Solutions Should Offer Ease of Use and Increased Efficiency
    • 5.3.8. V-Patch and Zensor: Remote monitoring From Intelesens
  • 5.4. Pipeline Projects
    • 5.4.1. CareLink System - Medtronic
    • 5.4.2. CX65KKKKK mobile phone - Siemens
    • 5.4.3. Telemonitoring System for Dementia Patients - Intel
    • 5.4.4. MDKeeper Wearable eHealth System - Aerotel Medical Systems

6. Leading Companies in the Telemedicine Market 2014

  • 6.1. 3M: A Global Health Information Systems Provider
    • 6.1.1. 3M Healthcare Revenue Analysis, 2013
    • 6.1.2. 3M's Telemedicine Products and Services
  • 6.2. Aerotel Medical Systems
    • 6.2.1. Aerotel's Products and Services
  • 6.3. AGFA Healthcare
    • 6.3.1. AGFA: Radiology and Imaging Solutions
  • 6.4. AMD Global Telemedicine Inc
    • 6.4.1. AMD Global Telemedicine's Products and Services
  • 6.5. CardioComm
    • 6.5.1. CardioComm Pipeline Products
  • 6.6. Honeywell HomMed
    • 6.6.1. Honeywell HomMed Telemedicine Products and Services
  • 6.7. Medtronic
    • 6.7.1. Medtronic: Revenue Analysis
    • 6.7.2. Medtronic's Telemedicine System
  • 6.8. Philips Healthcare
    • 6.8.1. Philips Healthcare: Revenue Analysis
  • 6.9. Siemens Healthcare
    • 6.9.1. Siemens Healthcare: Revenue Analysis
  • 6.10. Telcare
    • 6.10.1. Telcare's Market and Business Model
    • 6.10.2. Telcare's Products and Services

7. Qualitative Analysis

  • 7.1. SWOT Analysis of the Telemedicine Devices Market, 2014-2024
  • 7.2. Strengths
    • 7.2.1. The Increasing Prevalence of Diseases
    • 7.2.2. The Rising Popularity of Home Monitoring
    • 7.2.3. The Willingness of Telecommunication Companies to Invest
  • 7.3. Weaknesses
    • 7.3.1. The Threat of Replacement Perceived by Healthcare Professionals
    • 7.3.2. The Inter-dependence of Telemedicine and Other Infrastructure
  • 7.4. Opportunities
    • 7.4.1. Potential for Use in Clinical Trials
    • 7.4.2. Possibility of Integrating with Assisted Living
    • 7.4.3. Benefits to Society beyond Healthcare
  • 7.5. Threats
    • 7.5.1. The High Cost of Implementing Telemedicine
    • 7.5.2. High Barrier to Entry: A Strong Deterrent
    • 7.5.3. Reluctance of Organisations to Share and Exchange Knowledge

8. Expert Opinion

  • 8.1. Interview with Ms Stacey Force, Vice President of Marketing, Honeywell HomMed
    • 8.1.1. The Scope of Telemedicine, Telehealth and Telemonitoring
    • 8.1.2. On the Current State of the Telemedicine and Telehealth Market
    • 8.1.3. On the Size of the Telemonitoring Market
    • 8.1.4. Honeywell's Products and Service Offerings
    • 8.1.5. Honeywell's Plans for Expansion and Growth
    • 8.1.6. The Challenges Facing Telemedicine
    • 8.1.7. Technological Developments and their Potential Impact on the Market
    • 8.1.8. The Changing Reimbursement Model and Cost-Effectiveness
  • 8.2. Interview with Mr. Jason Gorevic, Chief Executive Officer, Teladoc
    • 8.2.1. Trends in the Development and Adoption of Telemedicine
    • 8.2.2. Teleadoc's Services and Healthcare Partnerships
    • 8.2.3. Plans for Future Expansion of Telemedicine Services and Mobile Engagement
    • 8.2.4. On the Challenges and Unmet Needs in the Market
    • 8.2.5. Technological Developments in Remote Healthcare Provision
    • 8.2.6. On the Future Prospects of Telemedicine
  • 8.3. Interview with Mr David Rubin, Chief Executive Officer, Aerotel Medical Systems
    • 8.3.1. Current State of Telemedicine
    • 8.3.2. Aerotel's Products and Service Offerings
    • 8.3.3. Challenges Facing Telemedicine and Telehealth
    • 8.3.4. Opportunities for Market Growth
  • 8.4. Interview with Mr Amnon Gavish, Senior Vice President of Vertical Solutions, Vidyo; and Mr Marty Hollander, Vidyo Evangelist, Vidyo
    • 8.4.1. Telepresence as a Means of Improving Healthcare Efficiency
    • 8.4.2. Vidyo's Teleconferencing Solutions
    • 8.4.3. Technological Advances in Telemedicine and its Effects on Market Dynamics
    • 8.4.4. Vidyo's Expansion and Growth Plans
    • 8.4.5. The Geographical Areas That Will Drive Telehealth Growth
    • 8.4.6. On the Future Potentials of Telemedicine and Teleconferencing
    • 8.4.7. On the Challenges and Opportunities in the Telemedicine Market

9. Conclusion

  • 9.1. Market Overview
  • 9.2. Telemedicine Devices for Diabetes Care Set for Rapid Growth
  • 9.3. Technologically Developed Economies will Drive Market Growth

List of Tables

  • Table 2.1: The US Classification of Medical Devices
  • Table 2.2: The EU Classification of Medical Devices
  • Table 3.1: The Medical Devices Market: Revenues ($bn) and Market Shares (%) by Sector, 2012
  • Table 3.2: The Global Telemedicine Devices Market: Revenue ($m) and Market Shares (%) by Sector, 2013
  • Table 3.3: The Global Telemedicine Devices Market: Market Forecast ($m, AGR%, CAGR%) by Sector, 2013-2024
  • Table 3.4: Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2013-2018, 2018-2024, 2013-2024
  • Table 3.5: The Global Telemedicine Devices Market: Revenue ($m) by Sector, 2013, 2018, 2024
  • Table 3.6: The Global Telemedicine Devices Market: Market Share (%) by Sector, 2013, 2018, 2024
  • Table 3.7: The Telemedicine Devices Market for Cardiac Diseases: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.8: The Telemedicine Devices Market for COPD and Asthma: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.9: The Telemedicine Devices Market for Diabetes: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.10: The Telemedicine Devices Market for Mental-health Related Illnesses: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 3.11: The Telemedicine Devices Market for Other Illnesses: Market Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.1: The Global Telemedicine Devices Market: Revenue ($m) and Market Share (%) by Region, 2013
  • Table 4.2: The Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2013-2024
  • Table 4.3: Telemedicine Devices Market Forecast: CAGR (%) by Region, 2013-2018, 2018-2024, and 2013-2024
  • Table 4.4: Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2013, 2018, 2024
  • Table 4.5: US Telemedicine Devices Market Forecast: Revenue ($m), Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.6: US Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.7: The EU5 Telemedicine Devices Market Forecast: Market Size ($m), Market Share (%) and CAGR (%), 2013-2024
  • Table 4.8: The EU5 Telemedicine Devices Market: Revenue ($m) and Market Share (%) by Country, 2013
  • Table 4.9: The EU5 Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%) by Country, 2013-2024
  • Table 4.10: EU5 Telemedicine Devices Market: Market Share (%) by Country, 2013, 2018, 2024
  • Table 4.11: The German Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.12: The German Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.13: The UK Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.14: The UK Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.15: The French Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.16: The French Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.17: The Spanish Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.18: The Spanish Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.19: The Italian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.20: The Italian Telemedicine Devices Market: Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.21: The Japanese Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.22: The Japanese Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.23: The Chinese Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.24: The Chinese Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.25: The South Korean Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.26: The South Korean Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.27: The Russian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.28: The Russian Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.29: The Indian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.30: The Indian Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 4.31: The Brazilian Telemedicine Devices Market Forecast: Revenue ($m), Market Rank, Market Share (%) and CAGR (%), 2013-2024
  • Table 4.32: The Brazilian Telemedicine Devices Market: Revenue Forecast ($m, AGR%, CAGR%), 2013-2024
  • Table 5.1: Devices, Mobile Technologies and Their Use in mHealth
  • Table 5.2: Mobile Health Apps and Their Features, 2014
  • Table 5.3: An Overview of Functions in mHealth
  • Table 5.4: Components of Intelesens' V-Patch System, 2014
  • Table 6.1: 3M: Revenue ($m) and Revenue Shares (%) by Franchise, 2012
  • Table 6.2: 3M: Historical Healthcare Revenue ($bn, AGR %), 2008-2012
  • Table 6.3: Aerotel Medical Systems' Products and Services, 2014
  • Table 6.4: AGFA Healthcare's Telemedicine Products and Services, 2014
  • Table 6.5: AMD Global Telemedicine's Products and Services, 2014
  • Table 6.6: CardioComm Pipeline Products and Descriptions, 2014
  • Table 6.7: Honeywell: Revenue ($bn) and Revenue Shares (%) by Sector, 2012
  • Table 6.8: Honeywell HomMed Products and Descriptions, 2014
  • Table 6.9: Medtronic: Revenues ($bn) and Revenue Shares (%) by Franchise, 2013
  • Table 6.10: Medtronic: Revenues ($bn) and Revenue Shares (%) by Region, 2013
  • Table 6.11: Philips Healthcare Medical Devices: Revenues ($bn) and Revenue Shares (%) by Sector, 2012
  • Table 6.12: Philips Healthcare: Revenues ($bn) and Revenue Shares (%) by Region, 2012
  • Table 6.13: Siemens Healthcare Medical Devices: Revenues ($bn) and Revenue Shares (%) by Region, 2012
  • Table 6.14: Telcare: Products and Descriptions, 2014
  • Table 7.1: Telemedicine Devices: Market Drivers and Restraints 2014-2024
  • Table 7.2: SWOT Analysis of the Telemedicine Devices Market, 2014-2024
  • Table 9.1: Global Telemedicine Devices: Market Forecast ($m, CAGR%), 2013, 2018, 2021, 2024
  • Table 9.2: Global Telemedicine Devices: Market Forecast ($m, CAGR%) by Sector, 2013, 2018, 2021, 2024
  • Table 9.3: Global Telemedicine Devices: Market Share (%) by Region, 2013, 2018, 2021, 2024

List of Figures

  • Figure 2.1: The Similarities and Differences Between Telecare and Telehealth
  • Figure 2.2: The Similarities and Differences Between Telehealth and Telemedicine
  • Figure 2.3: Global Deaths from Cardiovascular Diseases (millions), 2008, 2030
  • Figure 2.4: The Parties Involved in the Provision of mHealth
  • Figure 3.1: The Global Telemedicine Devices Market: Revenue ($m) by Sector, 2013
  • Figure 3.2: The Global Telemedicine Devices Market: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.3: Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2013-2018
  • Figure 3.4: Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2018-2024
  • Figure 3.5: Global Telemedicine Devices Market Forecast: CAGR (%) by Sector, 2013-2024
  • Figure 3.6: The Global Telemedicine Devices Market: Revenue ($m) by Sector, 2013, 2018, 2024
  • Figure 3.7: The Global Telemedicine Devices Market: Market Share (%) by Sector, 2013
  • Figure 3.8: The Global Telemedicine Devices Market: Market Share (%) by Sector, 2018
  • Figure 3.9: The Global Telemedicine Devices Market: Market Share (%) by Sector, 2024
  • Figure 3.10: The Telemedicine Devices Market for Cardiac Diseases: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.11: The Telemedicine Devices Market for COPD and Asthma: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.12: The Telemedicine Devices Market for Diabetes: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.13: The Telemedicine Devices Market for Mental-health Related Illnesses: Market Forecast ($m, AGR%), 2013-2024
  • Figure 3.14: The Telemedicine Devices Market for Other Illnesses: Market Forecast ($m, AGR%), 2013-2024
  • Figure 4.1: The Global Telemedicine Devices Market: Revenue ($m) by Region, 2013
  • Figure 4.2: US, EU5, Japan, and South Korea Telemedicine Devices Market: Revenue Forecast ($m), 2013-2024
  • Figure 4.3: Brazil, Russia, India, and China (BRIC) Telemedicine Devices Market: Revenue Forecast ($m), 2013-2024
  • Figure 4.4: Telemedicine Devices Market Forecast: CAGR (%) by Region, 2013-2018
  • Figure 4.5: Telemedicine Devices Market Forecast: CAGR (%) by Region, 2018-2024
  • Figure 4.6: Telemedicine Devices Market Forecast: CAGR (%) by Region, 2013-2024
  • Figure 4.7: Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2013
  • Figure 4.8: Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2018
  • Figure 4.9: Telemedicine Devices Market Forecast: Market Shares (%) by Region, 2024
  • Figure 4.10: US Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.11: The EU5 Telemedicine Devices Market: Market Size ($m) by Country, 2013
  • Figure 4.12: Germany, UK, France, Spain, and Italy Telemedicine Devices Market: Revenue Forecast ($m), 2013-2024
  • Figure 4.13: The EU5 Telemedicine Devices Market: Market Shares (%) by Country, 2013
  • Figure 4.14: The EU5 Telemedicine Devices Market: Market Shares (%) by Country, 2018
  • Figure 4.15: The EU5 Telemedicine Devices Market: Market Shares (%) by Country, 2024
  • Figure 4.16: The German Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.17: The UK Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.18: The French Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.19: The Spanish Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.20: The Italian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.21: The Japanese Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.22: The Chinese Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.23: The South Korean Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.24: The Russian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.25: The Indian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 4.26: The Brazilian Telemedicine Devices Market: Revenue Forecast ($m, AGR%), 2013-2024
  • Figure 5.1: Functions Where Telemedicine Solutions are Utilized
  • Figure 5.2: Global Deaths from Communicable and Non-Communicable Diseases (%)
  • Figure 6.1: 3M: Revenue Shares (%) by Franchise, 2012
  • Figure 6.2: 3M: Historical Healthcare Revenue ($bn), 2008-2012
  • Figure 6.3: Honeywell: Revenue Shares (%) by Sector, 2012
  • Figure 6.4: Medtronic: Revenue Shares (%) by Franchise, 2013
  • Figure 6.5: Medtronic: Revenue Shares (%) by Region, 2013
  • Figure 6.6: Philips Healthcare Medical Devices: Revenue Shares (%) by Sector, 2012
  • Figure 6.7: Philips Healthcare: Revenues ($bn) by Region, 2012
  • Figure 6.8: Siemens Healthcare Medical Devices: Revenue Shares (%) by Region, 2012
  • Figure 9.1: Global Telemedicine Devices: Market Forecast ($m, CAGR%), 2013, 2018, 2021, 2024
  • Figure 9.2: Global Over-60 Population Forecast (%): 1950, 2009, 2050
  • Figure 9.3: Global Telemedicine Devices: Market Forecast ($m, CAGR%) by Sector, 2013, 2018, 2021, 2024
  • Figure 9.4: Global Telemedicine Devices: Market Share (%) by Region, 2013, 2018, 2021, 2024

Companies Listed

  • 3M
  • Accenture
  • Aerotel Medical Systems
  • AGFA Healthcare
  • Allied Telesis
  • Almeda GMBH
  • AMD Global Telemedicine
  • Apple
  • AT&T
  • Bayer AG
  • Bosch Healthcare
  • CardioComm
  • Confidant Inc
  • Fast Company
  • Fitbit
  • Google
  • Honeywell
  • IBM
  • Ideal Life
  • INOVELAN
  • Intelesens Ltd
  • Medtronic
  • Microsoft
  • Mitra Imaging Inc [AGFA]
  • Nike
  • Philips Healthcare
  • Phyode
  • Polycom
  • Samsung
  • Sendsor
  • Shandong NovaTech BioPharmaceutical Ltd
  • SHL Telemedicine Ltd
  • Siemens
  • Tadiran Spectralink Ltd
  • Teladoc
  • Telcare
  • Telecom Italia
  • TRxCARE
  • Vidyo
  • Vodafone

Other Organisations Mentioned in This Report

  • American Telemedicine Association
  • Cellular Telephone Institute of America
  • Center for Disease Control [US]
  • Columbia University
  • Department of Health [UK]
  • Food and Drug Administration [US]
  • Health Resources Services Administration [US]
  • International Diabetes Federation
  • International Medical Device Regulators Forum
  • International Telecommunication Union
  • Ministry of Health [Kazakhstan]
  • National Committee for Quality Assurance [US]
  • National Health Service [UK]
  • South Carolina Heart Center
  • The American Heart Association
  • The Centres for Medicare and Medicaid Services [US]
  • The Japanese Red Cross Kitami Hospital
  • US Medicare and Medicaid Services, Health Care Financing Administration
  • Veteran's Health Administration [US]
  • Wireless Life Sciences Alliance
  • World Health Organisation
Back to Top